Eli Lilly has taken legal action against three entities involved in the unauthorized sale of products claiming to contain tirzepatide, a key ingredient in its weight-loss medication, Zepbound. The defendants named in the lawsuit are Pivotal Peptides, MangoRx, and Genesis Lifestyle Medicine of Nevada. This move marks the pharmaceutical company’s latest attempt to combat the...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here
